Lessons from April 6, 2009 L'Aquila earthquake to enhance microzoning studies in near-field urban areas

AbstractThis study focuses on two weak points of the present procedure to carry out microzoning study in near-field areas: (1) the Ground Motion Prediction Equations (GMPEs), commonly used in the reference seismic hazard (RSH) assessment; (2) the ambient noise measurements to define the natural frequency of the near surface soils and the bedrock depth. The limitations of these approaches will be discussed throughout the paper based on the worldwide and Italian experiences performed after the 2009 L'Aquila earthquake and then confirmed by the most recent 2012 Emilia Romagna earthquake and the 2016–17 Central Italy seismic sequence. The critical issues faced are (A) the high variability of peak ground acceleration (PGA) values within the first 20–30 km far from the source which are not robustly interpolated by the GMPEs, (B) at the level 1 microzoning activity, the soil seismic response under strong motion shaking is characterized by microtremors' horizontal to vertical spectral ratios (HVSR) according to Nakamura's method. This latter technique is commonly applied not being fully compliant with the rules fixed by European scientists in 2004, after a 3-year project named Site EffectS assessment using AMbient Excitations (SESAME). Hereinafter, some "best practices" from recent Italian and International experiences of seismic hazard estimation and microzonation studies are reported in order to put forward two proposals: (a) to formulate site-specific GMPEs in near-field areas in terms of PGA and (b) to record microtremor measurements following accurately the SESAME advice in order to get robust and repeatable HVSR values and to limit their use to those geological contests that are actually horizontally layered

A case report of treatment of a streptococcal brain abscess with ceftobiprole supported by the measurement of drug levels in the cerebrospinal fluid

In this paper, we describe the case of a patient admitted to our hospital because of a brain abscess due to Streptococcus intermedius. The management of brain abscess is challenging given the limited potential drug options with effective penetration into both the central nervous system and the abscess capsule to achieve adequate therapeutic concentrations. Due to the high anti-streptococcal activity of ceftobiprole and the availability of ceftobiprole therapeutic drug monitoring in our hospital, we decided to treat the patient with ceftobiprole. To maximize the antimicrobial effect of ceftobiprole, we chose a prolonged intravenous infusion, and we monitored its concentrations in both plasma and cerebrospinal fluid

Ampicillin and Ceftobiprole Combination for the Treatment of Enterococcus faecalis Invasive Infections: “The Times They Are A-Changin”

Background: Enterococcus faecalis is responsible for a large variety of severe infections. This study is a case series reporting our experience in the treatment of E. faecalis invasive infections with ampicillin in combination with ceftobiprole (ABPR). Methods: We retrospectively analyzed all the medical records of patients admitted to the University Hospital of Udine from January to December 2020 with a diagnosis of infective endocarditis or primary or non-primary complicated or uncomplicated bacteremia caused by E. faecalis. Results: Twenty-one patients were included in the final analysis. The clinical success rate was very high, accounting for 81% of patients, and microbiological cure was obtained in 86% of patients. One relapse was recorded in one patient who did not adhere to the partial oral treatment prescribed. Therapeutic drug monitoring (TDM) was always performed for ampicillin and ceftobiprole, and serum concentrations of both drugs were compared to the MICs of the different enterococcal isolates. Conclusions: ABPR is a well-tolerated antimicrobial regimen with anti-E. faecalis activity. TDM can help clinicians optimize medical treatments to achieve the best possible efficacy with fewer side effects. ABPR might be a reasonable option for the treatment of severe invasive infections caused by E. faecalis due to the high level of enterococcal penicillin-binding protein (PBP) saturation

The Highly Energetic Expansion of SN2010bh Associated with GRB 100316D

We present the spectroscopic and photometric evolution of the nearby (z = 0.059) spectroscopically confirmed type Ic supernova, SN 2010bh, associated with the soft, long-duration gamma-ray burst (X-ray flash) GRB 100316D. Intensive follow-up observations of SN 2010bh were performed at the ESO Very Large Telescope (VLT) using the X-shooter and FORS2 instruments. Owing to the detailed temporal coverage and the extended wavelength range (3000--24800 A), we obtained an unprecedentedly rich spectral sequence among the hypernovae, making SN 2010bh one of the best studied representatives of this SN class. We find that SN 2010bh has a more rapid rise to maximum brightness (8.0 +/- 1.0 rest-frame days) and a fainter absolute peak luminosity (L_bol~3e42 erg/s) than previously observed SN events associated with GRBs. Our estimate of the ejected (56)Ni mass is 0.12 +/- 0.02 Msun. From the broad spectral features we measure expansion velocities up to 47,000 km/s, higher than those of SNe 1998bw (GRB 980425) and 2006aj (GRB 060218). Helium absorption lines He I lambda5876 and He I 1.083 microm, blueshifted by ~20,000--30,000 km/s and ~28,000--38,000 km/s, respectively, may be present in the optical spectra. However, the lack of coverage of the He I 2.058 microm line prevents us from confirming such identifications. The nebular spectrum, taken at ~186 days after the explosion, shows a broad but faint [O I] emission at 6340 A. The light-curve shape and photospheric expansion velocities of SN 2010bh suggest that we witnessed a highly energetic explosion with a small ejected mass (E_k ~ 1e52 erg and M_ej ~ 3 Msun). The observed properties of SN 2010bh further extend the heterogeneity of the class of GRB supernovae.Comment: 37 pages and 12 figures (one-column pre-print format), accepted for publication in Ap

Serum uric acid and left ventricular mass index independently predict cardiovascular mortality: The uric acid right for heart health (URRAH) project

A relationship between serum uric acid (SUA) and cardiovascular (CV) events has been documented in the Uric Acid Right for Heart Health (URRAH) study. Aim: of this study was to investigate the association between SUA and left ventricular mass index (LVMI) and whether SUA and LVMI or their combination may predict the incidence of CV death. Methods: Subjects with echocardiographic measurement of LVMI included in the URRAH study (n=10733) were part of this analysis. LV hypertrophy (LVH) was defined as LVMI > 95 g/m2 in women and 115 g/m2 in men. Results: A significant association between SUA and LVMI was observed in multiple regression analysis in men: beta 0,095, F 5.47, P 5.6 mg/dl in men and 5.1 mg/dl in women) and LVH (log-rank chi-square 298.105; P<0.0001). At multivariate Cox regression analysis in women LVH alone and the combination of higher SUA and LVH but not hyperuricemia alone, were associated with a higher risk of CV death, while in men hyperuricemia without LVH, LVH without hyperuricemia and their combination were all associated with a higher incidence of CV death. Conclusions: Our findings demonstrate that SUA is independently associated with LVMI and suggest that the combination of hyperuricemia with LVH is an independent and powerful predictor for CV death both in men and women

Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study

High serum uric acid (SUA) and triglyceride (TG) levels might promote high-cardiovascular risk phenotypes across the cardiometabolic spectrum. However, SUA predictive power in the presence of normal and high TG levels has never been investigated. We included 8124 patients from the URic acid Right for heArt Health (URRAH) study cohort who were followed for over 20 years and had no established cardiovascular disease or uncontrolled metabolic disease. All-cause mortality (ACM) and cardiovascular mortality (CVM) were explored by the Kaplan-Meier estimator and Cox multivariable regression, adopting recently defined SUA cut-offs for ACM (&gt;= 4.7 mg/dL) and CVM (&gt;= 5.6 mg/dL). Exploratory analysis across cardiometabolic subgroups and a sensitivity analysis using SUA/serum creatinine were performed as validation. SUA predicted ACM (HR 1.25 [1.12-1.40], p &lt; 0.001) and CVM (1.31 [1.11-1.74], p &lt; 0.001) in the whole study population, and according to TG strata: ACM in normotriglyceridemia (HR 1.26 [1.12-1.43], p &lt; 0.001) and hypertriglyceridemia (1.31 [1.02-1.68], p = 0.033), and CVM in normotriglyceridemia (HR 1.46 [1.23-1.73], p &lt; 0.001) and hypertriglyceridemia (HR 1.31 [0.99-1.64], p = 0.060). Exploratory and sensitivity analyses confirmed our findings, suggesting a substantial role of SUA in normotriglyceridemia and hypertriglyceridemia. In conclusion, we report that SUA can predict ACM and CVM in cardiometabolic patients without established cardiovascular disease, independent of TG levels

Information on the origin of food products in the European market

RIASSUNTO Il mercato alimentare ha subito negli ultimi decenni profonde trasformazioni. Dalle vecchie piazze, in cui avvenivano gli scambi delle mercanzie, si è passati al mercato globalizzato senza confini. Il consumatore, se una volta acquistava gli alimenti incontrando e discutendo con il venditore, oggi sceglie i beni esposti negli scaffali. Le informazioni che consentono all’acquirente una scelta consapevole nel mercato dei prodotti agro-alimentari sono oggi fornite essenzialmente dall’etichetta, la carta d’identità dell’alimento. Tra le indicazioni che esercitano un importante ruolo competitivo nei mercati di alimenti nazionali ed esteri spicca quella del paese di origine, in grado di influenzare il processo decisionale del consumatore. Il tema dell’origine dei prodotti coinvolge diverse normative comunitarie e non presenta dei contorni uniformi, venendo associato alla provenienza, all’origine geografica, imprenditoriale o commerciale. La Comunità ha già reso obbligatorio nell’etichetta di alcuni alimenti il place of farming or origin, come nel caso delle carni bovine, dell’olio vergine ed extravergine di oliva, del miele, delle uova, dei prodotti da agricoltura biologica, ortofrutticoli e della pesca. A breve la Commissione europea adotterà delle norme di esecuzione per indicare l’origine della carne suina, ovina, caprina, di volatili e dell’ingrediente primario, e predisporrà delle relazioni sulla possibilità di estendere l’obbligo, tra gli altri, ad altre carni, al latte anche usato come ingrediente di prodotti lattiero-caseari, agli alimenti non trasformati, ai prodotti a base di un unico ingrediente e agli ingredienti che rappresentano più del 50 % di un alimento. In Italia sono state adottate iniziative tese ad estendere l’operatività del country of origin, sia a livello centrale, mediante delle regole che impongono l’origine nell’etichettatura della passata di pomodoro, del latte fresco, del pollame e della selvaggina allevata e cacciata e dei prodotti di montagna, sia a livello locale, attraverso la promozione di prodotti agricoli e alimentari muniti della certificazione “Denominazione Comunale d’origine”.ABSTRACT Over the past decades, huge changes have occurred in food marketing. We moved from an old market square, where people could buy or sell goods, to a global market without borders. While in the past the consumer purchased food by meeting and talking to the seller, now he simply chooses the goods on display on supermarket shelves. All the information that allow the consumer to make an informed choice in food marketing are now provided by the label, differently intended as the food’s identity card. Among those indications which have an important place in domestic and foreign food markets, the country of origin is the one which mostly affects the consumer’s decision making process. The indication of the food’s country of origin is related to a variety of Community regulations which differ not only as far its geographical origin is concerned, but also in its trading and commercialization. The food’s place of farming (or origin) is already binding for some EU products like beef, virgin and extra virgin olive oil, honey, eggs, organic products, fresh fruit, vegetables, and fish. Plus, in short the European Commission will issue some application acts concerning mandatory indication of the country of origin for pork, white meat, goat meat, poultry meat and primary ingredients, and will prospect reports regarding mandatory indication of the country of origin for other types of meat, milk (even when it is among the ingredients of dairy products), unprocessed food, single-ingredient products or ingredients which represent more than 50% of a product. Several initiatives have been taken in Italy, both at a central and a local level, to include the country of origin among the product information by means of rules that impose the indication of the country of origin for tomato sauce, fresh milk, poultry, farmed feathered game, wild birds, and mountain products by promoting agricultural products and foodstuffs called “Denominazioni comunali d’origine”

Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study

The Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension conceived and designed an ad hoc study aimed at searching for prognostic cut-off values of serum uric acid (SUA) in predicting combined (fatal and non-fatal) cerebrovascular (CBV) events in the whole database. The URic acid Right for heArt Health study is a nationwide, multicenter, observational cohort study involving data on subjects aged 18-95 years recruited on a regional community basis from all the territory of Italy under the patronage of the Italian Society of Hypertension with a mean follow-up period of 120.7 ± 61.8 months. A total of 14,588 subjects were included in the analysis. A prognostic cut-off value of SUA able to discriminate combined CBV events (&gt;4.79 mg/dL or &gt;284.91 µmol/L) was identified by means of receiver operating characteristic curve in the whole database. Multivariate Cox regression analysis adjusted for confounders (age, sex, arterial hypertension, diabetes, chronic kidney disease, smoking habit, ethanol intake, body mass index, low-density lipoprotein cholesterol, and use of diuretics) identified an independent association between SUA and combined CBV events in the whole database (HR 1.249, 95% confidence interval, 1.041-1.497, p = 0.016). The results of the present study confirm that SUA is an independent risk marker for CBV events after adjusting for potential confounding variables, including arterial hypertension, and demonstrate that &gt;4.79 mg/dL is a valid prognostic cut-off value